Insider Transactions in Q1 2021 at Oncotelic Therapeutics, Inc. (OTLC)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
Saran Saund Chief Business Officer |
BUY
Conversion of derivative security
|
Direct |
16,354,961
+50.0%
|
-
|
|
Mar 31
2021
|
Steven W King Director |
BUY
Conversion of derivative security
|
Indirect |
3,291,720
+49.71%
|
-
|
|
Mar 31
2021
|
Vuong Trieu CHAIRMAN AND CEO |
BUY
Conversion of derivative security
|
Indirect |
19,521,186
+45.22%
|
-
|
|
Mar 31
2021
|
Vuong Trieu CHAIRMAN AND CEO |
BUY
Conversion of derivative security
|
Direct |
74,455,719
+45.2%
|
-
|
|
Mar 31
2021
|
Anthony E Maida Iii Chief Clin. Ops. Officer |
BUY
Conversion of derivative security
|
Direct |
938,646
+45.22%
|
-
|